Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Accr2g02062 | ATGCAACTGAAAATTCTGCTCTTCTTCTGTTACATTTTCTGTTTCTCTTATGGTCTTGCTGCTGTTTTGAATGATGAAGTTTCTGCTCTACTTTTTATAAAAGCAGGTCTTATTGATCCGTTGAATAAGCTGCAAGATTGGAAATTGCAGGACAAGGCACCAAGAAAAGATGCAGCGCATTGTAACTGGGTTGGTGTCTCGTGCAATGCTGCTGGAGCTGTTGAGAAGCTTGATCTATCCCACATGAATCTCAGTGGCAGGGTATCCGATGAGATACAAAAGCTACAAAGTCTCTCTACTCTGAACTTATGCTGCAATGGATTCTCCACAACCTTGCCAAAATCTGTAGCCAACCTCACCACATTGAGAAGTCTTGATGTCAGCCAGAATTTATTCGTTGGTGATTTTCCATTAGGTCTTGGAAAGGCGTCACGACTTATGTTTTTTAATGCATCCGGTAATGATTTCTCAGGTTTTCTTCCTGAGGACCTTGGAAATGCTTCTTTCTTAGAGACGCTGGATCTCAGAGGCAGCTTCTCCCAAGGGTCTATTCCAAAATCGTTCAGTAGATTGCAGAAGTTGAGGTTCCTTGGTCTTTCTGGAAATAATCTCACTGGAGAAATTCCGGGAGATCTGGGACAGCTCTCCTCACTTGAGTATATGATACTCGGGTACAATTCATTTGAGGGTGGGATTCCCAGAGAGTTTGGAAATCTCACCAATCTCAAGTATCTTGATATGGCAGAAGGCAATCTTGGAGGTGAAATTCCAGCTGAATTGGGAAACCTGAAATTACTTAACACGGTTTTCTTATACAGAAACGATTTCAAAGGCAGAATCCCTCCTTCTTTGGGCAATCTGACTTCGTTGGTGTTGATGGATTTCTCTGATAACATGTTATCAGGAAAAATTCCACCTGAAATTGGTCAACTGAAGCATTTAGAGCTCCTAAATTTCATGAGCAACCTTCTATCTGGTCCTGTGCCTTCTGAAATTGGGGATTTGCCTCAATTGAAGGTTCTTGAGCTATGGAACAATTCCTTGTCAGGACCATTGCCAAACCACCTGGGCAAGAGTTCACCATTGCAGTGGCTTGATGTATCATCCAACTCTCTCTCTGGTGTGATTCCAGAAACACTTTGCAGCCAGGGCAATCTCACCAAGCTTATCCTTTTCAGTAATGCCTTCACAGGTCCAATCCCAGTCAACCTATCATCGTGCCCTTCACTTGTTCGTGTTCGAATTCATAACAATTTACTTAATGGGACGATTCCAGTCGGTTTTGGGAAACTTCGGAATCTTGAAAGGTTAGAATTGGCCAATAACAGTCTCACTGGTGAAATTCCAAATGACATTGCTTCTTCCACGTCTCTTTCGTTCATTGATTTCTCCAGAAACAACCTCCATTCTTCTCTCCCTTCTACTGTACTTTCTACTCCAAATCTCCAATCATTCTTGGTCTCCCACAACAATTTGGTGGGTGAAATCCCAGACCAATTTCAGGACTGTCCTTCACTCGGTGTTCTTGATCTGTCATCAAATCATCTCTCTGGAAGCATCCCAGCCAGCGTTGCTTCTTGTCAGAAACTGGTAAACTTGAACCTAAAGAACAACCAATTGATTGGTAAAATCCCGAAGGCACTAACAAATATGCCTTCGTTGGCCATTCTTGATTTTTCCAACAACTCTCTGACTGGTGAAATACCTGATAGCTTCGGTATTTCTCCTGCCCTGGAGGCTCTCAATGTCTCATACAACAGGCTTGAGGGTCCTGTCCCAACAAATGGCATGCTGAGAACCATTAACCCAAGTGATCTTGTGGGTAATGCTGGCCTATGTGGTGGCGTCCTTCCTCCATGTGGCCAAAACTCTGGATATGCATTGGAACATGGAAGCTCACGAGCAAAACACATAATCACAGGATGGGCAATTGGGATATCGTCAGTCTTGGCTATTGGGATTGCCATTTTTGTTGTCAGATCTATATACATAAGGTGGTACTCTCATGGCTTCTGCATTGGAGAAACGATTTATAAGGGTGACAAAAGGTGGCCCTGGAGATTGATGGCATTTCAGAGGCTTAATTTTACAAGCACTGAGATTCTAGCTTGCATCAAGGAAACAAATGTGATTGGAATGGGAGCAACTGGTGTTGTTTATATGGCTGAAATATCGCAGTCAAATACAATTGTGGCAGTGAAGAAGTTGTGGAAATCAGGATCTGATACTGAAGTAGGAAATAGTGATAACCTTGTTGGGGAGGTGAATCTCTTGGGTCGGCTAAGACATAGAAATATCGTTAGACTCTTAGGATATCTTTATAATGACGTTGATGTTATGATAGTTTATGAATTTATGTCTAATGGCAACCTTGGAGATGCCTTGCATGGCAAACACGCTGGTAGGTTGCTTGTAGACTGGGCTTCCCGTTATAAGATAGCTCTAGGAGTTGCCCAAGGGCTTGCTTATCTTCATTATGACTGTCATCCGCCGGTCATACACCGAGACATCAAGTCAAATAACATACTGCTTGATGCAAATCTTGAGGCAAGAATAGCAGATTTTGGATTAGCCAAAATGATGATCAGGAAGAACGAAACAGTCTCCATGATTGCTGGGTCCTACGGCTACATTGCCCCAGAATATGGATATTCCTTGAAGGTAGATGAAAAGATTGACACTTATAGCTATGGAGTAGTTCTGTTGGAGCTTCTCACAGGGAAGAGGCCCCTGGATTCTGAGTTTGGAGAATCTGTGGACATTGTTGAGTGGATTAGGAGGAAGATTAGAGACAACAAGCCTCTAGAAGAAGCATTAGACCCAAGTGTAGGAAACTGCAGGCATGTTGTGGAGGAGATGCTTTTAGTTCTTAGAATAGCACTTCTTTGCACTGCCAAGCTACCCAAAGACAGACCCTCCATGAGAGATGTGATAATGATTCTTGAAGAGGCAAAGCCTCGCAGTAAAAGCGATAGCAACGATAAAAAGCATGAAGCTAATAATAAGATGATGCCAGTTTTTAGCACATCATCACCCATTAGTGGCCTTGTGTAG | 3054 | 0.428 | MQLKILLFFCYIFCFSYGLAAVLNDEVSALLFIKAGLIDPLNKLQDWKLQDKAPRKDAAHCNWVGVSCNAAGAVEKLDLSHMNLSGRVSDEIQKLQSLSTLNLCCNGFSTTLPKSVANLTTLRSLDVSQNLFVGDFPLGLGKASRLMFFNASGNDFSGFLPEDLGNASFLETLDLRGSFSQGSIPKSFSRLQKLRFLGLSGNNLTGEIPGDLGQLSSLEYMILGYNSFEGGIPREFGNLTNLKYLDMAEGNLGGEIPAELGNLKLLNTVFLYRNDFKGRIPPSLGNLTSLVLMDFSDNMLSGKIPPEIGQLKHLELLNFMSNLLSGPVPSEIGDLPQLKVLELWNNSLSGPLPNHLGKSSPLQWLDVSSNSLSGVIPETLCSQGNLTKLILFSNAFTGPIPVNLSSCPSLVRVRIHNNLLNGTIPVGFGKLRNLERLELANNSLTGEIPNDIASSTSLSFIDFSRNNLHSSLPSTVLSTPNLQSFLVSHNNLVGEIPDQFQDCPSLGVLDLSSNHLSGSIPASVASCQKLVNLNLKNNQLIGKIPKALTNMPSLAILDFSNNSLTGEIPDSFGISPALEALNVSYNRLEGPVPTNGMLRTINPSDLVGNAGLCGGVLPPCGQNSGYALEHGSSRAKHIITGWAIGISSVLAIGIAIFVVRSIYIRWYSHGFCIGETIYKGDKRWPWRLMAFQRLNFTSTEILACIKETNVIGMGATGVVYMAEISQSNTIVAVKKLWKSGSDTEVGNSDNLVGEVNLLGRLRHRNIVRLLGYLYNDVDVMIVYEFMSNGNLGDALHGKHAGRLLVDWASRYKIALGVAQGLAYLHYDCHPPVIHRDIKSNNILLDANLEARIADFGLAKMMIRKNETVSMIAGSYGYIAPEYGYSLKVDEKIDTYSYGVVLLELLTGKRPLDSEFGESVDIVEWIRRKIRDNKPLEEALDPSVGNCRHVVEEMLLVLRIALLCTAKLPKDRPSMRDVIMILEEAKPRSKSDSNDKKHEANNKMMPVFSTSSPISGLV | 1017 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Accr2g02062 | 1017 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 832 | 844 | IPR008271 | GO:0004672|GO:0006468 | |
Accr2g02062 | 1017 | MobiDBLite | consensus disorder prediction | 985 | 1001 | - | - | |
Accr2g02062 | 1017 | Gene3D | Phosphorylase Kinase; domain 1 | 705 | 789 | - | - | |
Accr2g02062 | 1017 | ProSitePatterns | Protein kinases ATP-binding region signature. | 711 | 735 | IPR017441 | GO:0005524 | |
Accr2g02062 | 1017 | Gene3D | Transferase(Phosphotransferase) domain 1 | 790 | 1009 | - | - | |
Accr2g02062 | 1017 | Pfam | Leucine rich repeat | 480 | 540 | IPR001611 | GO:0005515 | |
Accr2g02062 | 1017 | Pfam | Leucine rich repeat | 408 | 468 | IPR001611 | GO:0005515 | |
Accr2g02062 | 1017 | Gene3D | Ribonuclease Inhibitor | 364 | 624 | IPR032675 | - | |
Accr2g02062 | 1017 | FunFam | Leucine-rich repeat receptor-like protein kinase PXL1 | 179 | 279 | - | - | |
Accr2g02062 | 1017 | FunFam | Leucine-rich repeat receptor-like protein kinase PXL1 | 364 | 624 | - | - | |
Accr2g02062 | 1017 | Pfam | Protein kinase domain | 707 | 976 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Accr2g02062 | 1017 | FunFam | Leucine-rich repeat receptor-like protein kinase PXL1 | 23 | 178 | - | - | |
Accr2g02062 | 1017 | Gene3D | Ribonuclease Inhibitor | 178 | 281 | IPR032675 | - | |
Accr2g02062 | 1017 | SUPERFAMILY | Protein kinase-like (PK-like) | 700 | 982 | IPR011009 | - | |
Accr2g02062 | 1017 | MobiDBLite | consensus disorder prediction | 985 | 1017 | - | - | |
Accr2g02062 | 1017 | SMART | serkin_6 | 705 | 980 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Accr2g02062 | 1017 | PANTHER | RECEPTOR-LIKE PROTEIN 55 | 431 | 985 | - | - | |
Accr2g02062 | 1017 | FunFam | MDIS1-interacting receptor like kinase 1 | 705 | 789 | - | - | |
Accr2g02062 | 1017 | Gene3D | Ribonuclease Inhibitor | 282 | 363 | IPR032675 | - | |
Accr2g02062 | 1017 | SUPERFAMILY | RNI-like | 272 | 590 | - | - | |
Accr2g02062 | 1017 | SMART | LRR_typ_2 | 551 | 575 | IPR003591 | - | |
Accr2g02062 | 1017 | SMART | LRR_typ_2 | 431 | 455 | IPR003591 | - | |
Accr2g02062 | 1017 | SMART | LRR_typ_2 | 287 | 311 | IPR003591 | - | |
Accr2g02062 | 1017 | SMART | LRR_typ_2 | 95 | 119 | IPR003591 | - | |
Accr2g02062 | 1017 | SMART | LRR_typ_2 | 335 | 359 | IPR003591 | - | |
Accr2g02062 | 1017 | SMART | LRR_typ_2 | 503 | 527 | IPR003591 | - | |
Accr2g02062 | 1017 | SMART | LRR_typ_2 | 191 | 215 | IPR003591 | - | |
Accr2g02062 | 1017 | MobiDBLite | consensus disorder prediction | 1003 | 1017 | - | - | |
Accr2g02062 | 1017 | Gene3D | Ribonuclease Inhibitor | 21 | 177 | IPR032675 | - | |
Accr2g02062 | 1017 | SUPERFAMILY | L domain-like | 60 | 349 | - | - | |
Accr2g02062 | 1017 | FunFam | MDIS1-interacting receptor like kinase 1 | 790 | 1000 | - | - | |
Accr2g02062 | 1017 | FunFam | Leucine-rich repeat receptor protein kinase EMS1 | 280 | 363 | - | - | |
Accr2g02062 | 1017 | Pfam | Leucine rich repeat N-terminal domain | 24 | 69 | IPR013210 | - | |
Accr2g02062 | 1017 | ProSiteProfiles | Protein kinase domain profile. | 705 | 988 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Accr2g02062 | Accr-Chr2 | 55614738 | 55617981 | Dispersed/Transposed |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Accr2g02062 | 1 | 1017 | Receptor kinase-like Gene Family | AT1G08590 | 57.763 | 0.0 | 1148 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
PK | RLK-Pelle_LRR-XI-1 | Accr2g02062 | Pkinase | 1.4e-46 | CL0016 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Accr2g02062 | - | - | gmx:100811284 | 1621.68 |